Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-κB decoy oligonucleotides
J. Clin. Invest. Stefan Fichtner-Feigl, et al. 115:3057
doi:10.1172/JCI24792 [Go to this article.]

Problems with a PDF?